Search

Your search keyword '"Dubot C"' showing total 10 results

Search Constraints

Start Over You searched for: Author "Dubot C" Remove constraint Author: "Dubot C" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
10 results on '"Dubot C"'

Search Results

1. Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial

2. Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study

3. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

4. Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial

5. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial

6. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

7. Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study

8. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

9. Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

10. Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

Catalog

Books, media, physical & digital resources